Press Release

ZIM Laboratories Limited has been granted marketing authorization for Sildenafil 50 mg ODS by AEMPS - The Spanish Agency for Medicine and Healthcare Products, for its European subsidiaries.

Zim Laboratories Limited has been granted marketing rights for Rizatriptan by Infarmed, for its European subsidiaries.

ZIM Laboratories Limited and Hypera Pharma Group enter into an exclusive licensing agreement of Vitamin D3 Orally Disintegrating Strips for Brazil Market

ZIM Laboratories Limited and Neuraxpharm enter into an exclusive co-development agreement

ZIM Labs Video Gallery

ZIM Labs image gallery

WhatsAppFor inquiries chat with us